Literature DB >> 15292290

Cardiovascular risk in PCOS.

David S Guzick.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15292290     DOI： 10.1210/jc.2004-1136

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

1.  Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.

Authors:  M Rizzo; R A Longo; E Guastella; G B Rini; E Carmina
Journal:  J Endocrinol Invest       Date:  2010-10-15       Impact factor: 4.256

Review 2.  Polycystic ovary syndrome in adolescence.

Authors:  Colleen Buggs; Robert L Rosenfield
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

3.  Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.

Authors:  Andrew J Krentz; Denise von Mühlen; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

Review 4.  The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.

Authors:  Anandita Agarwala; Erin D Michos; Zainab Samad; Christie M Ballantyne; Salim S Virani
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

5.  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Authors:  S Alsamarai; J M Adams; M K Murphy; M D Post; D L Hayden; J E Hall; C K Welt
Journal:  J Clin Endocrinol Metab       Date:  2009-10-21       Impact factor: 5.958

6.  Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.

Authors:  C Noel Bairey Merz; Leslee J Shaw; Ricardo Azziz; Frank Z Stanczyk; George Sopko; Glenn D Braunstein; Sheryl F Kelsey; Kevin E Kip; Rhonda M Cooper-DeHoff; B Delia Johnson; Viola Vaccarino; Steven E Reis; Vera Bittner; T Keta Hodgson; William Rogers; Carl J Pepine
Journal:  J Womens Health (Larchmt)       Date:  2016-06-06       Impact factor: 2.681

7.  Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Leslee J Shaw; C Noel Bairey Merz; Ricardo Azziz; Frank Z Stanczyk; George Sopko; Glenn D Braunstein; Sheryl F Kelsey; Kevin E Kip; Rhonda M Cooper-Dehoff; B Delia Johnson; Viola Vaccarino; Steven E Reis; Vera Bittner; T Keta Hodgson; William Rogers; Carl J Pepine
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

Review 8.  Polycystic ovary syndrome: clinical implication in perimenopause.

Authors:  Monika Lenart-Lipińska; Beata Matyjaszek-Matuszek; Ewa Woźniakowska; Janusz Solski; Jerzy S Tarach; Tomasz Paszkowski
Journal:  Prz Menopauzalny       Date:  2014-12-30

Review 9.  Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseases.

Authors:  Yu-Hsun Kao; Wan-Chun Chiu; Ming-I Hsu; Yi-Jen Chen
Journal:  Int J Fertil Steril       Date:  2013-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.